INS and type 2 diabetes mellitus: Insulin, a key anabolic hormone that facilitates cellular glucose uptake and inhibits hepatic glucose production, is typically initiated in T2DM patients when progressive pancreatic beta-cell dysfunction leads to insufficient endogenous insulin secretion and oral agents alone fail to achieve adequate glycemic control.